Spinal cord atrophy as a measure of severity of myelopathy in adrenoleukodystrophy.

Journal of Inherited Metabolic Disease
Stephanie I W van de StadtMarc Engelen

Abstract

All men and most women with X-linked adrenoleukodystrophy (ALD) develop myelopathy in adulthood. As clinical trials with new potential disease-modifying therapies are emerging, sensitive outcome measures for quantifying myelopathy are needed. This prospective cohort study evaluated spinal cord size (cross-sectional area - CSA) and shape (eccentricity) as potential new quantitative outcome measures for myelopathy in ALD. Seventy-four baseline magnetic resonance imaging (MRI) scans, acquired in 42 male ALD patients and 32 age-matched healthy controls, and 26 follow-up scans of ALD patients were included in the study. We used routine T1 -weighted MRI sequences to measure mean CSA, eccentricity, right-left and anteroposterior diameters in the cervical spinal cord. We compared MRI measurements between groups and correlated CSA with clinical outcome measures of disease severity. Longitudinally, we compared MRI measurements between baseline and 1-year follow-up. CSA was significantly smaller in patients compared to controls on all measured spinal cord levels (P < .001). The difference was completely explained by the effect of the symptomatic subgroup. Furthermore, the spinal cord showed flattening (higher eccentricity and smaller ante...Continue Reading

References

Feb 1, 1991·Journal of the American Geriatrics Society·D Podsiadlo, S Richardson
Jul 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·B M van GeelP G Barth
Apr 5, 2000·Journal of Neuropathology and Experimental Neurology·J M PowersH W Moser
May 31, 2001·Journal of Neuropathology and Experimental Neurology·J M PowersH W Moser
Feb 12, 2005·Archives of Physical Medicine and Rehabilitation·Hubertus J van HedelVolker Dietz
Jul 13, 2005·Archives of Neurology·Heike IsraelChristoph J Ploner
Apr 10, 2010·IEEE Transactions on Medical Imaging·Nicholas J TustisonJames C Gee
May 9, 2012·The Cerebellum·Camila F ChevisMarcondes C França
May 10, 2012·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·R M CastilhosL B Jardim
Nov 14, 2013·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Lucas M T BrancoMarcondes C França
Feb 1, 2014·Brain : a Journal of Neurology·Marc EngelenStephan Kemp
Nov 8, 2014·Neurology·Marlijn de BeerBjörn M van Geel
May 27, 2015·IEEE Transactions on Medical Imaging·Benjamin De LeenerSamuel Kadoury
Apr 14, 2016·Brain : a Journal of Neurology·Antonella CastellanoEttore Salsano
Jun 18, 2016·Nature Reviews. Endocrinology·Stephan KempMarc Engelen
Oct 11, 2016·NeuroImage·Benjamin De LeenerJulien Cohen-Adad
Feb 17, 2017·NeuroImage. Clinical·Milena de AlbuquerqueMarcondes Cavalcante França
Apr 8, 2017·The Cerebellum·Carlos Roberto MartinsMarcondes C França
Aug 14, 2018·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Courtney CasserlyJiwon Oh
Sep 27, 2018·The Journal of Clinical Endocrinology and Metabolism·Irene C HuffnagelFlorian Eichler
Feb 9, 2019·Orphanet Journal of Rare Diseases·Irene C HuffnagelMarc Engelen
Jun 10, 2019·Annals of Neurology·Giorgia QuerinUNKNOWN Predict to Prevent Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis Study Group
Jun 18, 2019·Journal of the Neurological Sciences·Jonathan ZurawskiRohit Bakshi

❮ Previous
Next ❯

Citations

Oct 14, 2020·Annals of Clinical and Translational Neurology·Wouter J C van BallegoijMarc Engelen
Jul 1, 2021·Neuropediatrics·Stephanie I W van de StadtMarc Engelen
Aug 18, 2021·Nature Protocols·Julien Cohen-AdadJunqian Xu

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT03231878

Software Mentioned

Spinal Cord Toolbox ( SCT
Spinal
Cord Toolbox

Related Concepts

Related Feeds

Adrenoleukodystrophy

Adrenoleukodystrophy (ALD), the most frequent peroxisomal disorder, is an X-linked disorder caused by a defect in the metabolism of long chain fatty acids leading to demyelination, neurodegeneration, and death. Here is the latest research.